ALFA Finder
08:26 IST
NSE
Business Update
Biocon Business Update
Biocon signed a licence agreement with Janssen to commercialise biosimilar Yesintek in nine more markets, including Australia, Brazil and China. No deal value is disclosed.
Biocon Ltd
Biocon Ltd news stories on ALFA NewsRead the news →- Share price
- ₹368.05
- Market cap
- ₹59,981 Cr
- Revenue (annual)
- ₹16,927 Cr
- Net profit (annual)
- ₹385.6 Cr
- P/E (TTM)
- 132.7×Sector 43.8×
- Promoter holding
- 44.68%+0.00% QoQ
- FII holding
- 8.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 2Earnings Call 2Results Update 1Partnership 1Management Change 1Financial Results 1Business Update 1Board Meeting Date 1
Time
1 announcement with these filters